Keywords
How to Cite
Abstract
Urinary bladder lesions represent one of the current challenges in modern urology and radiology. They include benign and malignant tumors, inflammatory pseudotumors, blood clots, and other pathological changes. Due to the similarity of clinical manifestations, radiological imaging methods play a crucial role in differentiating these lesions. Ultrasound (US), Computed Tomography (CT), Magnetic Resonance Imaging (MRI), multiparametric MRI, and the Vesical Imaging-Reporting and Data System (VI-RADS) are widely used to determine the nature, extent, and degree of malignancy of urinary bladder lesions. This article analyzes the differential diagnosis of urinary bladder lesions, the diagnostic capabilities of imaging modalities, and modern radiological approaches.
References
1. Panebianco V., Narumi Y., Altun E. et al. Multiparametric MRI for Bladder Cancer: VI-RADS Assessment System. European Urology, 2018.
2. Babjuk M., Burger M., Capoun O. et al. EAU Guidelines on Non-Muscle-Invasive Bladder Cancer. European Urology, 2024.
3. Takeuchi M., Sasaki S., Ito M. Diffusion-Weighted MRI of Bladder Cancer. Radiology, 2019.
4. Silverman S.G., Leyendecker J.R., Amis E.S. Imaging in the Diagnosis and Management of Bladder Cancer. AJR, 2017.
5. Wong-You-Cheong J.J., Woodward P.J., Manning M.A. Neoplasms of the Urinary Bladder. Radiographics, 2006.
6. Vargas H.A., Akin O. MRI of Bladder Cancer: Staging and Beyond. Current Urology Reports, 2021.
7. Turkbey B., Rosenkrantz A.B., Haider M.A. Multiparametric MRI Applications in Urologic Oncology. Radiologic Clinics of North America, 2020.
8. Kim B., Semelka R.C. Abdominal-Pelvic MRI. Wiley Blackwell, 2019.
9. Grainger R.G., Allison D.J. Diagnostic Radiology. Elsevier, 2021.
10. Campbell-Walsh-Wein Urology. 13th Edition